Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: phoenix_rising who wrote (1510)	10/1/2015 10:28:19 AM
From: Mirror Image	Read Replies (1) of 2026

It has been public information since the August Conference Call. Sandoz sold out all their Vitaros units in Germany and has not re-ordered in that country - in August. Let me guess. The doom and gloom party is out in force in the other boards ( IHUB, Yahoo, etc )? Sandoz has many other countries partnered to sell Vitaros in and has continued to re-order and sell in Belgium and Sweden, even as this event is investigated. On the other hand, Germany is one of the BIG markets in Europe. But if we look at the old Vitaros sales numbers, it wasn't like they were having a BIG impact. Management ( Pascoe ) mentioned that Majorelle and Recordati were having a BIG impact because they went after the first line users in their respective countries vs. the hard to treat populations that Sandoz and Takeda targeted. My guess is that Sandoz is probably going to change their strategy in Germany. And they might wait for the room temperature version to do it. I have not spoke to anybody - it's just a guess! Same scenario with Canada - not launching the cold version - will wait for room temperature ( we came up with that scenario on this board - a very long time ago ).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next